How to do targeted therapy for renal cancer
summary
The most common location of metastasis is lung, followed by bone, brain, liver and many other organs. Therefore, patients with advanced renal cell carcinoma can not achieve the therapeutic effect by surgery alone, and need to be treated by surgery combined with medical treatment.
How to do targeted therapy for renal cancer
First, cytotoxic drugs (i.e. chemotherapy) have been proved to be ineffective in the treatment of renal cell carcinoma. However, immune agents such as interferon, as the only method of medical treatment for advanced renal cell carcinoma in the past, the effect is not ideal. With the development of science, targeted therapy has become the standard treatment for advanced renal cell carcinoma. Targeted therapy has a good effect on advanced renal cell carcinoma. Compared with interferon commonly used in the past, targeted drugs can delay tumor progression, prolong the life of patients, significantly improve the quality of life of patients, and reduce the mortality of patients with advanced renal cell carcinoma; especially for patients with cancer metastasis, targeted drugs can effectively inhibit the growth of metastatic sites.
Second, the average survival time of patients with metastatic renal cell carcinoma was 12-14 months. The new targeted drugs can extend the survival time of about 2 years, which may vary greatly from several months to several years for each patient. Early and mid-term renal cell carcinoma can be effectively treated by surgery, while advanced renal cell carcinoma can be treated by targeted drugs combined with surgery. Compared with other cancers, the treatment of renal cancer is relatively mature, patients and their families should be optimistic, through reasonable treatment, let renal cancer become a kind of cancer that does not affect life.
Third: metastasis and recurrence of renal cell carcinoma does not mean death. After finding appropriate treatment, many patients can survive with tumor for a long time. Sunitinib has unique targets, such as PDGFR - α and CSF-1R, and has more advantages in the treatment of metastatic lesions of renal cell carcinoma. In addition, good communication can help patients build up confidence and actively treat.
matters needing attention
The best way to block renal cell carcinoma is to find the signal of renal cell carcinoma in time and treat it as soon as possible. Hematuria, low back pain and mass are the three typical symptoms of renal cell carcinoma. But it is often too late to treat these problems, and the curative effect will not be good. Therefore, the public must improve their health awareness and check the kidney B ultrasound once a year after the age of 40. At present, it is not difficult to make early diagnosis of renal cell carcinoma by comprehensive use of B-ultrasound, CT and MRI.
